Skip to main content

Bionovate realigns its strategy: from Quantify Yourself to Know Yourself

CHAM, Switzerland, Nov. 27, 2020 (GLOBE NEWSWIRE) — The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC (OTCPK:BIIO). 
Bionovate Technologies Corp. will focus on investments and the marketing of patents and licenses which bring healthcare and lifestyle diagnostics to the smartphone. With strong emphasis on digital transformation, the company intends to build an FDA-approved ecosystem of medical devices, biosensors and mobile applications to turn tests that were previously only done in physical labs into tests that can be carried through by anyone with a mobile device. Innovations in these fields are transforming some of the most promising, high-growth-opportunity segments in the medical device market worldwide. To this end, new products and services will be developed in the coming months on the basis of existing patents. The focus will be on the acquisition of medical data from non-invasive sources (e.g. ultrasound, impedance measurements, motion profiles, other visualisation procedures) and their direct connection to mighty Big Data platforms, which use machine learning and artificial intelligence to provide the data as simple and clear as possible for the end user. With these new methods of wearable biosensing, which go far beyond the signals recorded so far, health-conscious and sporty consumers can measure and implement their fitness and health goals much better. CEO Aleksandar Vucak: “A wide range of applications and digital services in the lifestyle and medical care sectors are possible here. The entire wearables market is facing major disruptions because much more wearable biosensing is finally becoming possible. Completely new methods of signal processing and innovative digital communication architectures.  We are just crossing the threshold from ‘Quantify Yourself’ to ‘Know Yourself’. In this wave of innovation that is about to hit the market, we want to make a contribution to ensuring that many people live more health-consciously, listen to their body’s warning signals early on and thus live better.”Bionovate Technologies Corp.
Gewerbestr. 10
6330 Cham
Switzerland
Press contact:
Sandra Meyer
Tel: +41 581 01 02 02
Mail: press@bionovate.com
 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.